Logo image
Meal Replacements in the Treatment of Adolescent Obesity: A Randomized Controlled Trial
Journal article   Open access   Peer reviewed

Meal Replacements in the Treatment of Adolescent Obesity: A Randomized Controlled Trial

Robert I. Berkowitz, Thomas A. Wadden, Christine A. Gehrman, Chanelle T. Bishop-Gilyard, Renee H. Moore, Leslie G. Womble, Joanna L. Cronquist, Natalie L. Trumpikas, Lorraine E. Levitt Katz and Melissa S. Xanthopoulos
Obesity (Silver Spring, Md.), v 19(6), pp 1193-1199
Jun 2011
PMID: 21151016
url
https://doi.org/10.1038/oby.2010.288View
Published, Version of Record (VoR) Open

Abstract

Endocrinology & Metabolism Life Sciences & Biomedicine Nutrition & Dietetics Science & Technology
Use of meal replacements (MRs) in lifestyle modification programs (LMPs) for obese adults significantly increases weight loss, compared with prescription of an isocaloric conventional diet (CD). This 12-month randomized trial examined 113 obese adolescents (mean +/- s.d. age of 15.0 +/- 1.3 years and BMI of 37.1 +/- 5.1 kg/m(2)) who were assigned to a LMP, combined with meal plans of 1,300-1,500 kcal/day of CD (self-selected foods) or MR (three SlimFast shakes, one prepackaged meal, five vegetable/fruit servings). After month 4 (phase 1), participants originally treated with MR were unmasked to their phase 2 (months 5-12) random assignment: continued use of MR (i.e., MR+MR) or transitioned to CD (i.e., MR+CD). Participants initially treated with CD in phase 1, continued with CD (i.e., CD). All three groups were treated for an additional 8 months (phase 2). Regression models were used to evaluate percentage change in BMI from baseline to month 4 (phase 1), months 5-12 (phase 2), and baseline to month 12. At month 4, participants assigned to MR (N = 65) achieved a mean (+/-s.e.) 6.3 +/- 0.6% reduction in BMI, compared to a significantly (P = 0.01) smaller 3.8 +/- 0.8% for CD participants (N = 37). In phase 2, BMI increased significantly (P < 0.001) in all three conditions, resulting in no significant (P = 0.39) differences between groups in percentage change in BMI at month 12. Across groups, mean reduction in BMI from baseline to month 12 was 3.4 +/- 0.7% (P < 0.01). Use of MR significantly improved short-term weight loss, compared with CD, but its continued use did not improve maintenance of lost weight.

Metrics

3 Record Views
69 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Endocrinology & Metabolism
Nutrition & Dietetics
Logo image